• DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi logo
  • DNDi logo
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Global Headquarters
      • DNDi DRC
      • DNDi East Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

UNITE Global Summit 2021

6-8 December 2021

Virtual event

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

The UNITE Global Summit is UNITE’s annual event to promote political impact & momentum towards ending infectious diseases as a global health threat. This year’s event aims to secure political leadership as a key determinant to a fairer and equitable global health ecosystem that promotes health & well-being for all.

Virtual panel session

Tackling a Silent Epidemic: How can political leadership accelerate Hepatitis C control and treatment?

Hosted by Hepatitis C PACT

Date: Monday, 6 December 2021
Time: 14:00-15:30 GMT

Speakers:

  • Tan Sri Dr Noor Hisham Abdullah, Director General of Health, Malaysia
  • Dr Mariam Jashi, EECA Regional Chair, UNITE and former President, Leading Group on Innovative Financing for Development
  • Sergey Golovin, Intellectual Property and Access Lead, International Treatment Preparedness Coalition, Eastern Europe and Central Asia
  • Dr Jorge Bermudez, Senior Professor/Researcher and Head of Department of Pharmaceutical Policies, National School of Public Health, Oswaldo Cruz Foundation (Fiocruz), Brazil
  • Dr Sania Nishtar, Special Assistant to the Prime Minister and Federal Minister, Ministry of Poverty Alleviation and Social Safety, Pakistan​

Moderator: Leena Menghaney, South-Asia Head and Global IP Advisor, MSF Access Campaign

Session overview

Hepatitis C virus (HCV) can lead to chronic liver disease, cirrhosis, cancer, and death. Of the 58 million people with chronic HCV, only 13% (an estimated 9.4 million people) have had access to adequate treatment. Continuing disparities in access to diagnosis and treatment stand in the way of reaching World Health Organization (WHO) goals of controlling hepatitis C by 2030, and low- and middle-income countries (LMICs) – home to 75% of those living with this viral illness – bear the overwhelming brunt of the global HCV burden.

Controlling HCV requires increased awareness and commitment among decision-makers in LMICs, roll-out of all-oral cures, scale-up of community-based testing to find the missing millions of undiagnosed people, and concerted effort to address domestic financial challenges that prevent the launch of national programmes.

This session will engage politicians, health ministries, advocates, and other key stakeholders in an exploration of the tools and actions needed to harness countries’ strategic capacity to ensure equitable access to HCV diagnosis and treatment and bring this silent epidemic to an end.

Access to innovation in health – Building hope for an equitable future

Hosted by UNITAID

Date: Monday, 6 December 2021
Time: 15:45-17:15 GMT

Addressing critical health barriers for the most vulnerable –innovative tools to address health emergencies, build resilient health systems and support universal health coverage

Moderator: Gisela Scaglia, Member of the Parliament, Argentina

Speakers:

  • Robert Matiru, Programme Management, UNITAID
  • François Bompart, Chair of the DNDi Access Committee, DNDi
  • Maureen Murenga, Alternate Board Member Representing communities living with the diseases

Building political will to end neglected tropical diseases

Hosted by Uniting to Combat NTDs & Wellcome Trust

Date: Tuesday, 7 December 2021
Time: 10:45-12:15 GMT

Translating research into policy and practice

Moderator: Tamar Ghosh, Chief Executive, The Royal Society of Tropical Medicine and Hygiene

Speakers:

  • Ymkje Stienstra, Professor of Medicine, tropical and poverty related infectious diseases, University of Gröningen
  • Isabela Ribeiro, Head Dynamic Portfolio Unit, DNDi
  • John Amuasi, Executive Director, African Research Network for Neglected Tropical Diseases (ARNTDs)

More information

  • Registration
  • UNITE Global Summit Programme
Hepatitis C

Other events

Loading...
28 June - 1 July 2022

Singapore

Global Health Security Conference 2022

7-10 June 2022

Virtual event

World Hepatitis Summit 2022

25 May 2022

Davos, Switzerland

An SDG target we can reach: Financing viral hepatitis elimination

16 May 2022, 1:00 PM Paris

Paris, France and online

Gouverner en temps de pandémie: Faire des produits de santé un bien commun mondial

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi logo
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License